Your patient with SSc and pulmonary arterial hypertension (PAH) is undergoing evaluation prior to initiation of oral riociguat. Creatinine clearance is 10 mL/min. What is the most appropriate starting ...

The same biological processes that drive aging — such as energy loss — may also contribute to lung diseases like chronic ...

Historically considered a sterile environment, the lung is now recognized to host a diverse microbial population. In healthy ...

One of the most striking claims in the review is that AI-based classification models can meet or exceed the performance of ...

Cardiac sarcoidosis (CS) was a complication in about 10% of pulmonary sarcoidosis (PS) cases, investigators reported in Respiratory Medicine. The retrospective study assessed the prevalence, incidence ...

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment ...

Considerable variability exists in the clinical presentations of pulmonary arterial hypertension (PAH). Greater understanding of the comorbidities observed in Chinese patients with PAH is urgently ...

First-ever use of Ebenbuild's Twinhale technology  in idiopathic pulmonary fibrosis lung modelsTrial results published in Nature Communications Munich, Germany - April 9, 2025 -- Ebenbuild, a company ...

The global chronic obstructive pulmonary disease market size is calculated at USD 23.55 billion in 2025 and is expected to ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas -- tiny clumps of immune cells that form in response to inflammation. It's the most inflammatory of the interstitial lung diseases ...

An Osaka Metropolitan University medical research team aimed to investigate the effects of respiratory muscle dysfunction on clinical outcomes related to chronic obstructive pulmonary disease (COPD).

Backed Nutritional Solution Targeting Respiratory and Liver Health Through Natural Detox PathwaysSheridan, April 05, 2025 ...